Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street Consumer Discretionary Select Sector SPDR ETF
XLY
|
+$1.04B |
| 2 |
Palo Alto Networks
PANW
|
+$957M |
| 3 |
Medtronic
MDT
|
+$433M |
| 4 |
Pinterest
PINS
|
+$422M |
| 5 |
Colgate-Palmolive
CL
|
+$396M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.38B |
| 2 |
Alphabet (Google) Class C
GOOG
|
+$967M |
| 3 |
Apple
AAPL
|
+$847M |
| 4 |
Meta Platforms (Facebook)
META
|
+$700M |
| 5 |
State Street Health Care Select Sector SPDR ETF
XLV
|
+$576M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 12.9% |
| 2 | Financials | 7.33% |
| 3 | Healthcare | 6.04% |
| 4 | Consumer Discretionary | 5.46% |
| 5 | Communication Services | 3.81% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3126
Five Point Holdings
FPH
$370M
| $274K | ﹤0.01% |
70,088
-274
| -0.4% | -$1.41K |
|
3127
Perella Weinberg Partners
PWP
$1.26B
| $274K | ﹤0.01% |
46,852
+8,333
| +22% | +$60.3K |
|
3128
Metropolitan Bank Holding Corp
MCB
$1.15B
| $273K | ﹤0.01% |
3,932
-19,829
| -83% | -$1.64M |
|
3129
Ecovyst
ECVT
$1.2B
| $272K | ﹤0.01% |
27,546
-2,292
| -8% | -$23.8K |
|
3130
Riskified
RSKD
$694M
| $272K | ﹤0.01% |
+61,182
| New | +$317K |
|
|
KAMN
3131
DELISTED
Kaman Corp
KAMN
| $272K | ﹤0.01% |
8,716
-13,804
| -61% | -$512K |
|
|
AVTA
3132
DELISTED
Avantax, Inc. Common Stock
AVTA
| $272K | ﹤0.01% |
14,725
-24,411
| -62% | -$444K |
|
3133
AdaptHealth
AHCO
$806M
| $271K | ﹤0.01% |
15,082
-9,070
| -38% | -$147K |
|
3134
Hannon Armstrong Sustainable Infrastructure Capital
HASI
$4.89B
| $271K | ﹤0.01% |
7,145
-11,243
| -61% | -$447K |
|
3135
McGrath RentCorp
MGRC
$2.97B
| $271K | ﹤0.01% |
3,576
-3,030
| -46% | -$247K |
|
3136
Worthington Enterprises
WOR
$2.83B
| $271K | ﹤0.01% |
10,004
-2,249
| -18% | -$65.2K |
|
|
TRTN
3137
DELISTED
Triton International Limited
TRTN
| $271K | ﹤0.01% |
5,152
-8,866
| -63% | -$536K |
|
|
BTRS
3138
DELISTED
BTRS Holdings Inc. Class 1 Common Stock
BTRS
| $271K | ﹤0.01% |
54,466
-14,765
| -21% | -$84.9K |
|
3139
Allient
ALNT
$1.89B
| $269K | ﹤0.01% |
11,773
-1,323
| -10% | -$32.5K |
|
3140
BridgeBio Pharma
BBIO
$16.2B
| $268K | ﹤0.01% |
29,438
-13,148
| -31% | -$110K |
|
3141
Maravai LifeSciences
MRVI
$922M
| $268K | ﹤0.01% |
9,410
+4,519
| +92% | +$143K |
|
3142
NRC Health Common Stock
NRC
$431M
| $268K | ﹤0.01% |
7,002
+2,578
| +58% | +$93.2K |
|
|
XM
3143
DELISTED
Qualtrics International Inc. Class A Common Stock
XM
| $268K | ﹤0.01% |
21,447
+18,470
| +620% | +$329K |
|
|
VLD
3144
DELISTED
Velo3D, Inc.
VLD
| $267K | ﹤0.01% |
5,519
+2,465
| +81% | +$288K |
|
|
TSP
3145
DELISTED
TuSimple Holdings Inc. Class A Common Stock
TSP
| $267K | ﹤0.01% |
37,024
+21,292
| +135% | +$194K |
|
3146
Citizens
CIA
$231M
| $266K | ﹤0.01% |
63,379
-8,601
| -12% | -$31K |
|
|
LPRO
3147
DELISTED
Open Lending Corp
LPRO
| $266K | ﹤0.01% |
26,017
+1,927
| +8% | +$25.8K |
|
|
ATAQ.U
3148
DELISTED
Altimar Acquisition Corp III Units
ATAQ.U
| $266K | ﹤0.01% |
27,127
| – | – |
|
3149
Argan
AGX
$8.28B
| $265K | ﹤0.01% |
7,105
-1,792
| -20% | -$68.6K |
|
3150
RBC Bearings
RBC
$17.9B
| $265K | ﹤0.01% |
1,432
-3,243
| -69% | -$576K |
|
Similar funds
Barclays's Q2 2022 Portfolio in Review
As of Q2 2022, Barclays held 5,544 positions worth $163B, up 28% from $128B the previous quarter. Its ten largest holdings account for 39% of the portfolio.
Barclays deployed $63.1B of net new capital in Q2 2022, opening 560 new positions and adding to 1,332 existing holdings. Its largest new stake was Fisker Inc.: 3,607,227 shares worth $30.9M.
By sector, the portfolio is most concentrated in Technology at 13% of assets, down from 22% a quarter earlier, followed by Financials and Healthcare.
On the sell side, the largest reduction was State Street SPDR S&P 500 ETF Trust, an estimated $1.38B trimmed.
- Barclays's largest Q2 2022 buy was Fisker Inc.: 3,607,227 shares worth $30.9M.
- Barclays added most to State Street Consumer Discretionary Select Sector SPDR ETF in Q2 2022, an estimated $1.04B increase.
- Barclays's biggest Q2 2022 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $1.38B.
- Barclays fully exited Cerner Corp in Q2 2022, selling an estimated $432M.
- Barclays's ten largest holdings make up 39% of its $163B portfolio in Q2 2022.
- Barclays opened 560 new positions and closed 413 in Q2 2022.
- Barclays's portfolio value rose 28% quarter-over-quarter to $163B.
Based on Barclays's 13F filing for Q2 2022, filed 12 Aug 2022.